Lenalidomide/melphalan/dexamethasone in newly diagnosed patients with immunoglobulin light chain amyloidosis: results of a prospective phase 2 study with long-term follow up

Chemotherapy in light chain amyloidosis aims to normalize the involved free light chain in serum, which leads to an improvement, or at least stabilization of organ function in most responding patients. We performed a prospective single center phase 2 trial with 50 untreated patients not eligible for...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Haematologica
Hlavní autoři: Hegenbart, Ute, Bochtler, Tilmann, Benner, Axel, Becker, Natalia, Kimmich, Christoph, Kristen, Arnt V., Beimler, Jörg, Hund, Ernst, Zorn, Markus, Freiberger, Anja, Gawlik, Marianne, Goldschmidt, Hartmut, Hose, Dirk, Jauch, Anna, Ho, Anthony D., Schönland, Stefan O.
Médium: Artigo
Jazyk:Inglês
Vydáno: Ferrata Storti Foundation 2017
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5541875/
https://ncbi.nlm.nih.gov/pubmed/28522573
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2016.163246
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky